a multicenter trial was conducted at 9 neurology departments to evaluate the action of l-deprenyl , a specific monoamine oxidase-b inhibitor , combined with l-dopa in the treatment of parkinson disease .
C0023570
l-dopa
C0030567
parkinson disease